{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:16:06Z","timestamp":1788988566217,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurobiologyofaging.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.neurobiolaging.2016.08.004","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T11:10:32Z","timestamp":1471691432000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Andr\u00e9e-Anne","family":"Poirier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lissa","family":"C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Morissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u00e9r\u00e8se","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Soulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.lfs.2011.03.010","article-title":"The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson's disease","volume":"88","author":"Baraka","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/j.bbadis.2015.07.004","article-title":"GPER: a new tool to protect dopaminergic neurons?","volume":"1852","author":"Bessa","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fendo.2011.00035","article-title":"Male\/female differences in neuroprotection and neuromodulation of brain dopamine","volume":"2","author":"Bourque","year":"2011","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.neurobiolaging.2012.05.022","article-title":"Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease","volume":"34","author":"Bourque","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib6","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/j.neurobiolaging.2014.03.017","article-title":"Raloxifene activates G protein-coupled estrogen receptor 1\/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice","volume":"35","author":"Bourque","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/syn.1067","article-title":"Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl\/6 mice","volume":"41","author":"Callier","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20682","article-title":"Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease","volume":"58","author":"Chen","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib12","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JPD-140422","article-title":"Appraisal of the dopaminergic and noradrenergic innervation of the submucosal plexus in PD","volume":"4","author":"Corbille","year":"2014","journal-title":"J.\u00a0Parkinsons Dis."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib14","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's Guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2015.05.017","article-title":"GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease","volume":"82","author":"Cote","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbi.2011.02.017","article-title":"The critical role of the MyD88-dependent pathway in non-CNS MPTP-mediated toxicity","volume":"25","author":"Cote","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib17","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.bbi.2015.01.009","article-title":"Partial depletion of the proinflammatory monocyte population is neuroprotective in the myenteric plexus but not in the basal ganglia in a MPTP mouse model of Parkinson's disease","volume":"46","author":"Cote","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsbmb.2011.07.002","article-title":"Identification of a GPER\/GPR30 antagonist with improved estrogen receptor counterselectivity","volume":"127","author":"Dennis","year":"2011","journal-title":"J.\u00a0Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","article-title":"Colonic inflammation in Parkinson's disease","volume":"50","author":"Devos","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3565(24)38923-2","article-title":"Molecular mechanisms of selective estrogen receptor modulator (SERM) action","volume":"295","author":"Dutertre","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib22","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jocn.2007.02.095","article-title":"Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: a retrospective cohort study","volume":"15","author":"Etminan","year":"2008","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib23","doi-asserted-by":"crossref","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.yfrne.2014.02.002","article-title":"Sex differences in Parkinson's disease","volume":"35","author":"Gillies","year":"2014","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroimage.2004.11.012","article-title":"Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior","volume":"25","author":"Goekoop","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001756-200002070-00024","article-title":"Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice","volume":"11","author":"Grandbois","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5414\/CPP41331","article-title":"Review on raloxifene: profile of a selective estrogen receptor modulator","volume":"41","author":"Heringa","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib30","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2174\/1568026615666150610142027","article-title":"Collateral damage: contribution of peripheral inflammation to neurodegenerative diseases","volume":"15","author":"Herrera","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0165-0270(95)00064-X","article-title":"Cuprolinic blue (quinolinic phthalocyanine) counterstaining of enteric neurons for peroxidase immunocytochemistry","volume":"62","author":"Holst","year":"1995","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/gme.0b013e3181bd54df","article-title":"Raloxifene improves verbal memory in late postmenopausal women: a randomized, double-blind, placebo-controlled trial","volume":"17","author":"Jacobsen","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib33","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00702-013-1013-1","article-title":"Gender differences in cholinergic and dopaminergic deficits in Parkinson disease","volume":"120","author":"Kotagal","year":"2013","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib36","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1136\/gut.2008.162503","article-title":"Pathological lesions in colonic biopsies during Parkinson's disease","volume":"57","author":"Lebouvier","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1460-9568.2009.06873.x","article-title":"The second brain and Parkinson's disease","volume":"30","author":"Lebouvier","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib38","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1365-2982.2009.01368.x","article-title":"Routine colonic biopsies as a new tool to study the enteric nervous system in living patients","volume":"22","author":"Lebouvier","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib39","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","article-title":"Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms","volume":"5","author":"Lebouvier","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1440-1681.2007.04616.x","article-title":"Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease","volume":"34","author":"Liu","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib41","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jocn.2013.12.016","article-title":"Sex differences in Parkinson's disease","volume":"21","author":"Lubomski","year":"2014","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib43","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2016.08.004_bib44","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib45","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/mds.23388","article-title":"Gender differences in Parkinson's disease: clinical characteristics and cognition","volume":"25","author":"Miller","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib46","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson's disease: role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1095\/biolreprod.108.071175","article-title":"GPR30 does not mediate estrogenic responses in reproductive organs in mice","volume":"80","author":"Otto","year":"2009","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib48","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1210\/en.2008-0269","article-title":"G\u00a0protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol","volume":"149","author":"Otto","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib49","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1007\/s13277-015-4399-6","article-title":"Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma","volume":"37","author":"Pal","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2008.02.074","article-title":"Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?","volume":"153","author":"Phillips","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib51","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fasebj.10.8.8666168","article-title":"Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats","volume":"10","author":"Sato","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib52","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-3-211-45295-0_57","article-title":"Role of cytokines in inflammatory process in Parkinson's disease","author":"Sawada","year":"2006","journal-title":"J.\u00a0Neural Transm. Suppl."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/mds.23838","article-title":"Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease","volume":"27","author":"Shannon","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib55","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OGX.0b013e31816400d7","article-title":"Selective estrogen receptor modulators: an update on recent clinical findings","volume":"63","author":"Shelly","year":"2008","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"Stoger","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib58","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2010-0536","article-title":"Update in hormone therapy use in menopause","volume":"96","author":"Taylor","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib59","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.20856","article-title":"Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease","volume":"21","author":"Ton","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib60","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","article-title":"American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction","volume":"27","author":"Visvanathan","year":"2009","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib61","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF00294234","article-title":"Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system","volume":"79","author":"Wakabayashi","year":"1990","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib62","first-page":"10","article-title":"Parkinson's disease: prevalence, diagnosis and impact","volume":"25","author":"Wong","year":"2014","journal-title":"Health Rep."},{"key":"10.1016\/j.neurobiolaging.2016.08.004_bib63","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.162.4.683","article-title":"Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial","volume":"162","author":"Yaffe","year":"2005","journal-title":"Am. J. Psychiatry"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016301725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458016301725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T11:06:05Z","timestamp":1749553565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458016301725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":63,"alternative-id":["S0197458016301725"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.004","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}